iTAg Tetramer/PE - HLA-A*02:01 HTLV-1 (LLFGYPVYV)

Catalog No:
MBL-TS-M017-1

Availability: 12PM PT on Dec. 3, 2024

Formerly Catalog No.: TB-M017-1

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications
Application FC
Reactivity Human
Conjugation PE
Peptide Sequence LLFGYPVYV

Citations for iTAg Tetramer/PE - HLA-A*02:01 HTLV-1 (LLFGYPVYV) – 1 Found
Kozako, Tomohiro; Yoshimitsu, Makoto; Akimoto, Masaki; White, Yohann; Matsushita, Kakushi; Soeda, Shinji; Shimeno, Hiroshi; Kubota, Ryuji; Izumo, Shuji; Arima, Naomichi. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders. Human Immunology. 2011;72(11):1001-6.  PubMed